We are thrilled to share an opinion paper published in the Dermatology and Therapy Journal, advancing the diagnosis of late-onset reactions (LORs), the risks for and the management of these potential complications to hyaluronic acid (HA) dermal fillers. HA fillers are widely used in aesthetic medicine for their effectiveness in enhancing facial features and reducing wrinkles. Despite their generally positive benefit/risk profile, Late Onset Reactions (LOR) can occur, making their prevention and prompt management essential for patient well-being. The Complication Assessment and Risk Evaluation (CARE) Board, a group of renowned specialists in aesthetic medicine convened by TEOXANE, has identified three main causes of LOR: 1. Filler Structure: Low molecular weight HA fillers may trigger immune responses. 2. Infections: Bacteria introduced into the skin during injection, due to poor aseptic conditions, or reactivated from dormant states such as biofilms. 3. Patient Immune System Status: Autoimmune diseases or viral infections. To mitigate these risks, proper patient selection, maintaining high-quality standards during injections, and educating patients on post-procedure care are crucial. The authors provide guidelines and recommendations, which include a risk assessment questionnaire and a treatment algorithm, to aid practitioners in preventing and managing LORs, ensuring safer experiences for patients. At Teoxane, we are dedicated to safety and excellence in aesthetic medicine, continually enhancing patient care and upholding the highest industry standards. #Teoxane #AestheticMedicine #DermalFillers #PatientSafety #MedicalExcellence #Innovation
TEOXANE Laboratories
Herstellung medizinischer Geräte
Geneva, GE 20.487 Follower:innen
Info
When Madame Valérie Taupin created TEOXANE Laboratories in Geneva in 2003, her vision was crystal clear: to satisfy the ever demanding aesthetic market with high performance, avant-garde products based on rigorous scientific research. Today our focus remains unchanged. We are dedicated to designing and manufacturing hyaluronic acid dermal fillers and skincare products, applying industry-leading expertise and high-quality standards. Building on a firm commitment to innovation and patient satisfaction, we have strengthened our presence. In 2023, TEOXANE has over 10 subsidiaries and is present in more than 95 countries worldwide. TEOXANE is now confirmed as a major player in aesthetic medicine and skincare, offering effective solutions to practitioners worldwide, helping women and men who want to look and feel their best at all times and help them maintain their beauty in the future. Our core values of Innovation, Culture of Excellence and Independence continue to set us apart and guide our ambitions.
- Website
-
http://www.teoxane.com
Externer Link zu TEOXANE Laboratories
- Branche
- Herstellung medizinischer Geräte
- Größe
- 201–500 Beschäftigte
- Hauptsitz
- Geneva, GE
- Art
- Privatunternehmen
- Spezialgebiete
- Medical device, Aesthetic products, Skincare, Beauty, Anti-aging solutions, Aesthetic medicine, Dermal fillers, Dermis redensification und Hyaluronic Acid
Orte
-
Primär
Rue de Lyon 105
Geneva, GE 1203, CH
Beschäftigte von TEOXANE Laboratories
Updates
-
We are deeply honored to announce that Teoxane has been recognized as one of "Switzerland's Best Managed Companies" for the second year in a row! This esteemed recognition, awarded by Deloitte, was presented during a ceremony in Zurich on June 27th, 2024. For over 20 years our success has been driven by three core objectives: - Innovation: Constantly evolving to stay ahead of market demands. - Safety & Satisfaction: Prioritizing the well-being of patients and the satisfaction of practitioners. - Global Excellence: Aiming for the highest standards in every facet of our global operations. This award is a testament to the hard work and dedication of our exceptional teams and the trust of our valued partners and clients. #Teoxane #BestManagedCompanies #Deloitte #Innovation #Excellence #Healthcare #MedicalEducation
-
Our latest research, "Creation and Validation of a Photonumeric Scale for Assessment of Midface Volume Deficit," was presented at the SCALE Congress, held from May 15-19, 2024. We are always eager to contribute to the ongoing conversation and development within the medical community. Stay tuned for more updates as we continue to push the boundaries of medical research and innovation! #Teoxane #SCALECONGRESS #Nashville #Midfaceanatomy #medicaleducation
-
Upcoming Webinar Series: "Advancing Periorbital Treatments: The Teoxane Approach" We are thrilled to announce our exclusive webinar series, with invaluable insights from top experts in the field of periorbital treatments. For for the first session Dr. Lee Walker and Dr Philippe Berros will share their extensive experience in periorbital treatments. Learn about the integration of Redensity 2 into their practices, and how they've evolved their techniques for better patient outcomes. Expect to walk away with expert takeaways, personal experiences, and practical tips! In our second session, delve deeper into strategies for avoiding and managing complications in periorbital treatments with Dr. Sabrina Shah-Desai. Building on the insights from Webinar 1, this discussion will equip you with the knowledge to navigate challenges effectively. 🔗 Registration links : Webinar 1: https://lnkd.in/exvVigVC Webinar 2: https://lnkd.in/e7Eck9eB #Webinar #Teoxane #PeriorbitalTreatments #MedicalAesthetics #ExpertInsights #Redensity2 #ContinuingEducation #ProfessionalDevelopment
-
This year, Teoxane is pleased to welcome more than 15 students for varied and educational internships in our Medical Affairs, Clinical Affairs, Supplier and System Quality Assurance, Quality Control, IT, Metrology, Qualification & Validation, Process Validation teams and Supply Chain. Pascal Brice, our Chief Technical Officer, welcomed the class of 2024 Interns to the Teoxane Academy as part of an exciting presentation on his journey, his main achievements and the challenges ahead for Teoxane! #Teoxane #HumanResources #TalentManagement #Internships #Recruitment
-
We are pleased to announce two significant appointments to our leadership team at Teoxane. Anne Jaeckin - Chief Human Resources Officer effective April 29, 2024. With extensive experience from global organizations including BD, Avery Dennison, and COTY, where she served as the CHRO, Anne brings a wealth of expertise in HR leadership. Her strategic acumen and commitment to fostering an inclusive workplace culture will be instrumental as we advance our international growth and organizational transformation efforts. Alexandre Caratsch - General Counsel effective April 29th, 2024. With over three decades of legal experience, including senior roles at AC Immune, Medtronic, and Novartis, Alexandre brings a great knowledge in Swiss law and international regulations. His appointment underscores our dedication to legal excellence and strategic leadership as we navigate our global expansion initiatives. Please join us in extending a warm welcome to Anne and Alexandre as they embark on their new roles at Teoxane. Their expertise and leadership will undoubtedly contribute to our continued success and growth! #Teoxane #LeadershipAnnouncement #HR #LegalExcellence #GlobalExpansion
-
The Teoxane Academy Injection Show, held on April 20, 2024, at the Corinthia Hotel in Budapest, Hungary, was a resounding success. The event attracted over 300 participants from 25 different countries, demonstrating the global reach and impact of Teoxane products. Well done Team!
Reflecting on an unforgettable experience at III Teoxane Academy in Budapest! 🌍✨ With over 300 attendees from across Europe, this event was nothing short of extraordinary. Huge thanks to all our partners and the beautiful city of Budapest for making this gathering a resounding success! Thanks to our speakers. Thank you to everyone who contributed to making III Teoxane Academy an enriching and unforgettable event! Here's to continued growth and learning in the field of aesthetic medicine. 🙌 #TeoxaneAcademy #AestheticMedicine #BudapestExperience #MedicalEducation #InnovationInMedicine
-
Discover this new course by Dr. Lee Walker and Dr. Billur Sezgin Kizilok to learn more about the anatomy of the middle- and lower- third and evidence-based injection techniques to mitigate potential risks of complications when injecting Hyaluronic-Acid (HA)-based products in aesthetic indications. This module is accredited with 1 ECMEC credits valid in 27 countries and is available via the Xpeer Medical Education platform.
-
Another resounding success for Teoxane this year at AWMC ! You were 691 attendees at our symposium, THANK YOU ! Olivia Oliveri François BOURDON Romain Brusini Jimmy Faivre #TEOXANEXAMW #AMWC2024 #thankyou #Medicaleducation #MasteringAestheticChallenge
-
A special shoutout to our amazing employees & KOLs who are the driving force behind our success at AMWC. From showcasing our latest products, giving insightful presentations to engaging with industry experts and attendees, their commitment to excellence shines through in every interaction. Let's keep the momentum going! #TeoxaneXAMWC #AMWC2024 #AestheticMedicine #TeamWork #Innovation #Passion #Excellence
-
+3